Soluble guanylate cyclase: a potential therapeutic target for heart failure
Mihai Gheorghiade(Northwestern University), Javed Butler(Jackson Memorial Hospital), Stephen J. Greene(Duke Medical Center), Michael Böhm(Saarland University), John G.F. Cleland(University of Glasgow), Piotr Ponikowski(Wroclaw Medical University), Marco Metra(Vita-Salute San Raffaele University), Sean P. Collins(Wayne State University), Umberto Campia(Northwestern University), Gregg C. Fonarow(UCLA Medical Center), Adriaan A. Voors(University Medical Center Groningen), Naoki Sato(British Heart Foundation), Hani N. Sabbah(Henry Ford Hospital), Phillip D. Levy(Wayne State University), John C. Burnett(Mayo Clinic in Arizona), Johannes-Peter Stasch(Bayer (United States)), Lothar Roessig(Bayer (Germany)), Catherine N. Marti(Emory University), Bertram Pitt(University of Michigan)
Cited by 155
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
|European Journal of Heart Failure|2016|5.9k